Markets

How Does the Fundamental Picture Look for Anthera Pharmaceuticals, Inc. (ANTH)?

It’s worth it to have a look at Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) as there may be a chasm between the bulls and the bears as far as recent trading activity goes. Now trading with a market value of 7.59M, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For ANTH, the company currently has 8.09 million of cash on the books. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 8.81 million in total assets, balanced by 3.35 million in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Anthera Pharmaceuticals, Inc. (ANTH) saw -9.38 million in free cash flow last quarter, representing a quarterly net change in cash of 5.89 million. Perhaps most importantly where cash movements are concerned, the company saw about -9.38 million in net operating cash flow.

But what about the bottom line? After all, that’s what really matters in the end. Anthera Pharmaceuticals, Inc. (ANTH) is intriguing when broken down to its core data. The cost of selling goods last quarter was 161,000, yielding a gross basic income of -161,000 . For shareholders, given the total diluted outstanding shares of 22.17 million, this means overall earnings per share of -0.42. Note, this compares with a consensus analyst forecast of -0.52 in earnings per share for its next fiscal quarterly report.

Is Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) Valuation Attractive



Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about -1.78 in total earnings per share. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Anthera Pharmaceuticals, Inc..

Previous ArticleNext Article

Related Post

The Fundamental Facts on Turquoise Hill Resources ... Turquoise Hill Resources Ltd. (NYSE:TRQ) seems to be forming a pattern of major movements, providing only some crumbs of outlook for market participan...
VEREIT, Inc. (VER): Does This Move Make Any Sense ... VEREIT, Inc. (NYSE:VER) seems to be forming a pattern of major movements, providing only some crumbs of outlook for market participants trying to figu...
How Does the Fundamental Picture Look for CBS Corp... CBS Corporation (NYSE:CBS) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of 19.64B, the...
Checking Out the Fundamental Data for Alta Mesa Re... Alta Mesa Resources, Inc. (NASDAQ:AMR) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of...
How Does the Fundamental Picture Look for Calpine ... Calpine Corporation (NYSE:CPN) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision. Now t...